ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Is Thymic Function Determining Rejection Onset in Heart Transplantation?

A. Sannier,1,2 R. Dorent,1,3 M. Le Borgne,1 N. Stroumza,1 J. Senemaud,1 L. Louedec,1 F. Andreata,1 A. Gaston,1 C. Deschildre,1 P. Nataf,1,3 A. Couvelard,2 G. Caligiuri,1 A. Nicoletti.1

1Inserm U1148, Diderot University, Paris, France
2Pathology Department, Bichat Hospital, Paris, France
3Cardiac Surgery Department, Bichat Hospital, Paris, France

Meeting: 2017 American Transplant Congress

Abstract number: B11

Keywords: Heart transplant patients, Rejection, T cells, Thymus

Session Information

Session Name: Poster Session B: Acute and Chronic Rejection

Session Type: Poster Session

Date: Sunday, April 30, 2017

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

The thymus is the primary site of T cell development, involuting into fatty tissue in adults. Thymic function persists in the adulthood and may be boosted in certain circumstances. We questioned whether heart transplantation (HTx) was such a clinical situation and whether the thymic function was related to the onset of rejection.

Methods: HTx patients (n=28) received an induction therapy of antithymocyte globulin followed by maintenance immunosuppression. An allograft rejection event was defined as either acute cellular rejection (ACR) grade 2R or higher (n=5) or acute antibody-mediated rejection (AMR) as a pathological AMR2 or higher (n=6) (ISHLT guidelines). Analysis of peripheral blood mononuclear cells of HTx patients was performed by flow cytometry. Intrathymic proliferation of precursor T cells was evaluated through measurement of the sj/βTREC ratio. The effect of thymectomy was tested on the alloimmune humoral response in a rat model of aortic allograft (AA).

Results: A lower proportion of circulating CD4+ and CD8+ T cells with a recent thymic emigrant (RTE) phenotype (CD45RA+ CD62L+ CD31+) was observed in HTx patients than in non-HTx subjects. Strikingly, among HTx patients, AMR patients had a higher proportion of CD4+ RTE cells (p<0.01 vs no rejection and p<0.05 vs ACR). The percentage of CD4+ RTE cells was positively correlated with the sj/β TREC ratio and because we found no difference in IL-15 plasma levels between the different groups of HTx patients, we suggest that they have a thymic origin rather than resulting from homeostatic proliferation. Altogether, these results indicated that a better thymic function might predispose HTx patients for AMR. This hypothesis was supported by experimental data obtained in the AA model where we found a significant positive correlation between RTE CD4+ T cells (%) and DSA level. Remarkably, rats developed significantly less DSA and had lower levels of IL-4, IL-5, and IL-17A if they were thymectomized before the AA.

Conclusion: Our study strongly suggests that thymic function is a major determinant of AMR onset in HTx patients and that thymectomy might be a prophylactic strategy to prevent alloimmune humoral responses and/or to dampen established alloimmune humoral responses.

CITATION INFORMATION: Sannier A, Dorent R, Le Borgne M, Stroumza N, Senemaud J, Louedec L, Andreata F, Gaston A, Deschildre C, Nataf P, Couvelard A, Caligiuri G, Nicoletti A. Is Thymic Function Determining Rejection Onset in Heart Transplantation? Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Sannier A, Dorent R, Borgne MLe, Stroumza N, Senemaud J, Louedec L, Andreata F, Gaston A, Deschildre C, Nataf P, Couvelard A, Caligiuri G, Nicoletti A. Is Thymic Function Determining Rejection Onset in Heart Transplantation? [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/is-thymic-function-determining-rejection-onset-in-heart-transplantation/. Accessed May 29, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences